• Generation of a fully infectious SARS-CoV-2 encoding an internally tagged nsp3 02.11.2026

• Factors Associated with SARS-CoV-2 and Influenza A Positivity and In-Hospital Mortality Among Hospitalized Patients with Suspected Acute Respiratory Infection:
  A Retrospective Cohort Study 02.11.2026

• Molecular Therapeutic Development Against SARS-CoV-2:
  Structural Insights and Comparative Cellular Antiviral Evaluation with Established Antivirals 02.11.2026

• Association of Innate Immune Responses with SARS-CoV-2 Positivity in Children Under Five Years Old 02.11.2026

• Figure S1 from Deconvolving SARS-CoV-2 mRNA Vaccine Impact on Immunotherapy-Related Survival 02.11.2026

• Data from Deconvolving SARS-CoV-2 mRNA Vaccine Impact on Immunotherapy-Related Survival 02.11.2026

• Figure S3 from Deconvolving SARS-CoV-2 mRNA Vaccine Impact on Immunotherapy-Related Survival 02.11.2026

• Figure S4 from Deconvolving SARS-CoV-2 mRNA Vaccine Impact on Immunotherapy-Related Survival 02.11.2026

• Figure S6 from Deconvolving SARS-CoV-2 mRNA Vaccine Impact on Immunotherapy-Related Survival 02.11.2026

• Figure S2 from Deconvolving SARS-CoV-2 mRNA Vaccine Impact on Immunotherapy-Related Survival 02.11.2026

• Figure S5 from Deconvolving SARS-CoV-2 mRNA Vaccine Impact on Immunotherapy-Related Survival 02.11.2026

• STROBE checklist 1 from Deconvolving SARS-CoV-2 mRNA Vaccine Impact on Immunotherapy-Related Survival 02.11.2026

• Supplementary Tables S1-S2 from Deconvolving SARS-CoV-2 mRNA Vaccine Impact on Immunotherapy-Related Survival 02.11.2026

• Palladium(II) aminoadamantane complexes:
  a promising approach to impair SARS-CoV-2 infection 02.11.2026

• Association of COVID-19 with neurodegenerative and neurological disorders in vaccinated and unvaccinated people 02.11.2026

• Reported rhythm and conduction abnormalities in children and adolescents with SARS-CoV-2 infection:
  a systematic review and meta-analysis 02.11.2026

• Correction:
  SARS‑CoV‑2 envelope protein triggers depression‑like behaviors and dysosmia via TLR2‑mediated neuroinflammation in mice 02.11.2026

• Dual-Format Plasmonic Biosensors for the Detection of SARS-CoV-2 and the Oxidative Stress Biomarker sNOX2-dp 02.11.2026

• Crystallographic fragment screening in cancer and antiviral drug discovery:
  from electron density to translational outcomes. 01.11.2026

• Correction:
  SARS‑CoV‑2 envelope protein triggers depression‑like behaviors and dysosmia via TLR2‑mediated neuroinflammation in mice. 01.11.2026

• Is SARS-CoV-2 Infection (COVID-19) Associated With Congenital Anomalies? A Population Study of Congenital Anomaly Surveillance Data and Maternal SARS-CoV-2 Infection in Wales. 01.11.2026

• Independent Evaluation of Four SARS-CoV-2 Antigen Rapid Tests Against qRT-PCR in Niger 01.11.2026

• Creutzfeldt-Jakob disease following SARS-CoV-2 infection with rapid neurological decline:
  a case report 01.11.2026

• A Comparative study to Evaluate the Relative Gene Expression of the PML-II Gene in SARS-COV-2 Infected and Uninfected People 01.11.2026

• Evaluation of Gene Xpert Xpress System for Detecting SARS-CoV-2 in Suspected Clinical Samples 01.11.2026

• HEMATOLOGICAL AND RENAL BIOMARKERS IN CRITICALLY ILL PATIENTS WITH COVID-19 IN A BRAZILIAN ICU:
  A RETROSPECTIVE COHORT STUDY. 31.10.2026

• Identifying phase separation modulators mediated by the SARS-CoV-2 nucleocapsid protein using a structure-based drug discovery approach. 31.10.2026

• The Impact of Socioeconomic and Geographic Factors in Respiratory Virus Testing in Australia. 31.10.2026

• Immunization with JN.1 spike protein increases the breadth of binding and neutralizing antibodies in Syrian hamsters in an immune-history dependent manner. 31.10.2026

• Global burden of type 2 diabetes attributable to SARS-CoV-2 infection 31.10.2026

• Identifying phase separation modulators mediated by the SARS-CoV-2 nucleocapsid protein using a structure-based drug discovery approach 31.10.2026

• Induction of Caspase-7 Serum and P53 Gene Expression in Severe Omicron Variant SARS-CoV-2 Infection 31.10.2026

• Comparative Genomics of SARS-CoV and SARS-CoV-2 Using Fuzzy Sets:
  Insights into Viral Therapeutic Implications 31.10.2026

• Time to resolution of Long COVID symptoms and the associated factors among the people infected with SARS-CoV-2 during the 3rd wave of COVID-19 in Zambia:
  A prospective quantitative study 31.10.2026

• Author Correction:
  Inactivated vaccine-elicited potent antibodies can broadly neutralize SARS-CoV-2 circulating variants. 30.10.2026

• Mitigation of imprinted antibody responses against COVID-19 in highly vaccinated older adults. 30.10.2026

• Differential expression of lung-homing chemokine receptors in severe COVID-19:
  distinct profiles between Alpha and Omicron. 30.10.2026

• Causal discovery and inference in COVID-19:
  A multiscale longitudinal analysis using mixtures of DAGs. 30.10.2026

• Alcohol use and its associations with mental health across the first year of the COVID-19 pandemic. 30.10.2026

• Identification of broad-spectrum inhibitors for the cryptic binding site of SARS-CoV-2 NSP1 across multiple variants using molecular dynamics simulation. 30.10.2026

• Comparative analysis of production and kinetic assay conditions and parameters for SARS-CoV-2 main protease (Mpro):
  a systematic review. 30.10.2026

• Rapid Screening of Early SARS-CoV-2 Variants of Concern by Pyrosequencing 30.10.2026

• Structurally integrated BP@PDA@AuNR hybrid balls for low-power and high-precision SARS-CoV-2 detection via photothermal RT-LAMP 30.10.2026

• GLOW-CRISPR:
  A G-Quadruplex Loop-Engineered Optical Workflow Combined with CRISPR-Cas12a System for SARS-CoV-2 Detection 30.10.2026

• T‐Cell Response After SARS ‐ CoV ‐2 Vaccination in Patients With Hematological Malignancy 30.10.2026

• Effect of HLA Class II polymorphism on susceptibility to SARS-CoV-2 infection and severity of the infection process 30.10.2026

• Interleukin-1β in peripheral blood of pregnant women with mild and moderate course of acute SARS-CoV-2 infection 30.10.2026

• Open Government and Transparent Policy:
  China's Experience with SARS 30.10.2026

• Vaccination rates, facilitators and barriers for influenza, pneumococcal and SARS-CoV-2 vaccination among sepsis survivors:
  a Mid-German Sepsis Cohort survey 30.10.2026

• Author Correction:
  Inactivated vaccine-elicited potent antibodies can broadly neutralize SARS-CoV-2 circulating variants 30.10.2026

• Prevalence of antigens and antibodies against SARS-CoV-2 in people deprived of liberty 30.10.2026

• Prevalência de antígenos e anticorpos contra SARS-CoV-2 em pessoas privadas de liberdade 30.10.2026

• Recommendations for enhancing COVID-19 test and treat programmes in four African countries:
  insights and strategies from a qualitative study. 29.10.2026

• Discovery of 3-phenyldibenzo[b,d]furan derivatives as potent multi-stage inhibitors against SARS-CoV-2. 29.10.2026

• Feasibility of Mini Group Interpersonal Psychotherapy (IPT-G Mini) for Kenyan Adolescents. 29.10.2026

• Persistent COVID-19 Symptoms in General Population and Healthcare Workers:
  Systematic Review With Meta-Analysis. 29.10.2026

• From Brain Structure to Stress Response:
  COVID-Specific Anxiety Links Pre-Pandemic Gray Matter Volume to Changes in Life Satisfaction. 29.10.2026

• SARS-CoV-2 membrane (M) protein activates TLR4 to induce an inflammatory response. 29.10.2026

• Simultaneous detection of influenza and SARS-CoV-2 on an AI-nanopore multiplex platform. 27.10.2026

• SARS-CoV-2 ORF6 protein targets IFP35 to inhibit the IFNγ signaling pathway. 26.10.2026

• Polymorphism of amyloid fibrils of a SARS-CoV-2 peptide associated with hemagglutination. 26.10.2026

• Low-dose prednisolone and B vitamins for post-COVID-19 syndrome in Germany:
  the PreVitaCOV randomised clinical trial. 24.10.2026

• First evidence of an association between alexithymia and reduced humoral immunity following COVID-19 vaccination, independent of insomnia and metabolic factors in healthcare workers. 23.10.2026

• Molecular evidence of SARS-CoV-2 detection on cockroaches in Shiraz, southwestern Iran and potential implications for mechanical carriage. 23.10.2026

• Receptor-binding autoantibodies are not associated with post-COVID fatigue. 23.10.2026

• Formulation optimisation of an mRNA-lipid nanoparticle platform sustains in vivo production of the SARS-CoV-2-neutralizing nanobody VHH 72. 23.10.2026

• The pan-African natural products library compounds oleanolic acid, poinsettifolin B, and rhuschalcone III disrupt SARS-CoV-2 spike-host ACE2 interactions and SARS-CoV-2 replication. 21.10.2026

• Fitting and Selection of Within-Host Models for SARS-CoV-2 Infection 20.10.2026

• Pathogen-associated heterogeneity in pulmonary sepsis:
  from inflammatory phenotypes and transcriptomic endotypes to precision medicine. 16.10.2026

• Global burden of type 2 diabetes attributable to SARS-CoV-2 infection. 16.10.2026

• Temporal trends in semen quality at a single reproductive center in Shanghai, China, during 2021-2025 amid the COVID-19 pandemic. 16.10.2026

• Respiratory viral triggers and pediatric acute necrotizing encephalopathy:
  a systematic review and meta-analysis of risk, clinical phenotype, and outcomes. 16.10.2026

• Spatiotemporal evolution of SARS-CoV-2 Omicron variant and its lineages in India:
  Insights from geographic zone-based phylogenomics. 16.10.2026

• The Water-Soluble [60]Fullerene Derivatives as Binders of SARS-CoV‑2 Proteins 16.10.2026

• Evolution of SARS-CoV-2 reshapes upper airway immunity in children 16.10.2026

• Global burden of type 2 diabetes attributable to SARS-CoV-2 infection. 16.10.2026

• Iron Status in Patients with SARS-CoV-2 Infection. 15.10.2026

• Scaling of SARS-CoV-2 Genomic Divergence with Cumulative COVID-19 Infections. 15.10.2026

• SARS-CoV-2 nucleocapsid protein hijacks host transcription by targeting eEF1A1. 14.10.2026

• National public health institutes are essential to improve health security across the Eastern Mediterranean Region. 13.10.2026

• Error correction of SARS-CoV-2 genomic sequences using a phylogenetic prior 09.10.2026

• SARS-CoV-2 seeds IAPP aggregation and β-cell failure. 09.10.2026

• Transcriptional responses of white-tailed deer to SARS-CoV-2 challenge 07.10.2026

• Social inequalities in SARS-CoV-2 infection in France:
  An intersectional analysis 01.10.2026

• Influenza A (H1N1) and SARS-CoV-2 Transmission in Airplanes:
  Quanta Profiles and Infection Control. 01.10.2026

• Divergent systemic and airway mucosal adaptive immunity to SARS-CoV-2 in African adults 29.09.2026

• The other immune landscape of SARS-CoV-2 evolution. 28.09.2026

• Epistasis and the changing fitness landscapes of SARS-CoV-2. 17.09.2026

• N6-methyladenosine as a potential epitranscriptomic immune rheostat during SARS-CoV-2 infection 17.09.2026

• Role of Ion Channels in the Pathophysiology of SARS-CoV-2. 16.09.2026

• Healthy vaccinee effect in SARS-CoV-2 vaccinees without documented infection 11.09.2026

• Excess mortality related to the COVID-19 pandemic by age, sex, and cause of death in the Czech Republic. 10.09.2026

• Gut microbial allies and adversaries in SARS-CoV-2 infection. 10.09.2026

• Epitope-driven polyfunctional divergence of SARS-CoV-2 RBD antibodies 07.09.2026

• Worsening of Leigh syndrome or Guillain-Barre syndrome after SARS-CoV-2 Vaccination. 01.09.2026

• A Selenium-Deficient Mouse Model of Mouse-Adapted SARS-CoV-2 Demonstrates Variant Emergence Observed in SARS-CoV-2 Pandemic Variants 26.08.2026

• Antibody-mediated SARS-CoV-2 entry and conformational regulation. 21.08.2026

• Ingavirin as a potentially effective treatment for coronavirus:
  An investigative study of patient outcomes. 18.08.2026

• Etiology and co-infection patterns of acute respiratory viral infections in Bhopal, India:
  insights from short-term molecular study. 11.08.2026

• The effects of SARS-CoV-2 on bone homeostasis. 03.08.2026

Quellen: PubMed, Europe PMC & CrossRef